MedPath

Paired Vagus Nerve Stimulation (VNS) With Rehabilitation for Upper Limb Function Improvement After Stroke

Not Applicable
Completed
Conditions
Stroke
Interventions
Device: Vivistim System
Other: Rehab Only
Registration Number
NCT01669161
Lead Sponsor
MicroTransponder Inc.
Brief Summary

Patients (UK only) at least 6 months post stroke, with upper limb deficits, may enroll. Patients will be randomized to one of two groups - a group implanted with a device that allows pairing VNS with rehabilitation and a group that only receives rehabilitation (no implant). Patients have two baseline evaluations, one evaluation after implant but before initiation of treatment, and then six weeks of rehabilitation or rehabilitation + VNS, followed by post acute therapy evaluations at 1, 7, and 30 days after the 6-weeks of treatment. The intent is to assess safety and provide preliminary effectiveness information for VNS for upper limb functional improvement after stroke. Implanted patients may receive longer-term treatment and follow-up after the acute study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  1. History of unilateral supratentorial ischemic stroke that occurred at least 6 months prior
  2. Age > 18 years and < 80 years
  3. Right or left sided weakness of upper extremity

Major

Exclusion Criteria
  1. Hemorrhagic stroke
  2. Any deficits in language or attention that interferes with reasonable study participation
  3. Presence of significant apraxia
  4. Profound Sensory loss
  5. Active major neurological or psychiatric diagnosis that would likely interfere with study protocol including alcohol or drug abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
VNSVivistim SystemVNS (vagus nerve stimulation) paired with rehabilitation as provided by the Vivistim System.
Rehab OnlyRehab OnlyRehabilitation only (no implant, no VNS)
Primary Outcome Measures
NameTimeMethod
Safety6-weeks

Assessment of adverse events and serious adverse events.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

U. Glasgow / Western Infirmary

🇬🇧

Glasgow, Scotland, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath